Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study

BACKGROUND: This study examined the effects of lisdexamfetamine dimesylate (LDX) on quality of life (QOL) in adults with attention-deficit/hyperactivity disorder (ADHD) and clinically significant executive function deficits (EFD). METHODS: This report highlights QOL findings from a 10-week randomize...

Descripción completa

Detalles Bibliográficos
Autores principales: Adler, Lenard A, Dirks, Bryan, Deas, Patrick, Raychaudhuri, Aparna, Dauphin, Matthew, Saylor, Keith, Weisler, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854089/
https://www.ncbi.nlm.nih.gov/pubmed/24106804
http://dx.doi.org/10.1186/1471-244X-13-253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854089/
https://www.ncbi.nlm.nih.gov/pubmed/24106804
http://dx.doi.org/10.1186/1471-244X-13-253

Ejemplares similares